Literature DB >> 11978254

Do delayed prescriptions reduce the use of antibiotics for the common cold? A single-blind controlled trial.

B Arroll1, T Kenealy, N Kerse.   

Abstract

OBJECTIVE: To test the use of a delayed prescription compared with instructions to take antibiotics immediately in patients presenting to family physicians with upper respiratory tract infections (common colds). STUDY
DESIGN: Randomized controlled single-blind study. POPULATION: Subjects were 129 patients presenting with the common cold who requested antibiotics or whose physicians thought they wanted them. All patients were in a family practice in Auckland, New Zealand, consisting of 15 physicians (9 male, 6 female) who had completed medical school between 1973 and 1992. OUTCOMES MEASURED: Outcomes were antibiotic use (taking at least 1 dose of the antibiotic), symptom scores, and responses to the satisfaction questions asked at the end of the study.
RESULTS: Patients in the delayed-prescription group were less likely to use antibiotics (48%, 95% CI, 35%-60%) than were those instructed to take antibiotics immediately (89%, 95% CI, 76%-94%). Daily body temperature was higher in the immediate-prescription group. The lack of difference in the symptom score between the 2 groups suggests that there is no danger in delaying antibiotic prescriptions for the common cold.
CONCLUSIONS: Delayed prescriptions are a safe and effective means of reducing antibiotic consumption in patients with the common cold. Clarification of patient expectations for antibiotics may result in a lower prescription rate. When the patient demands a prescription, delaying its delivery has the potential to provide gentle education.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978254

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  14 in total

1.  Delayed prescriptions.

Authors:  Bruce Arroll; Tim Kenealy; Felicity Goodyear-Smith; Ngaire Kerse
Journal:  BMJ       Date:  2003-12-13

2.  Delayed prescribing for upper respiratory tract infections: a qualitative study of GPs' views and experiences.

Authors:  Sigurd Høye; Jan Frich; Morten Lindbœk
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

3.  Postdated versus usual delayed antibiotic prescriptions in primary care: Reduction in antibiotic use for acute respiratory infections?

Authors:  Graham Worrall; Angela Kettle; Wendy Graham; Jim Hutchinson
Journal:  Can Fam Physician       Date:  2010-10       Impact factor: 3.275

Review 4.  Interventions to improve antibiotic prescribing practices in ambulatory care.

Authors:  S R Arnold; S E Straus
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 5.  How long does a cough last? Comparing patients' expectations with data from a systematic review of the literature.

Authors:  Mark H Ebell; Jerold Lundgren; Surasak Youngpairoj
Journal:  Ann Fam Med       Date:  2013 Jan-Feb       Impact factor: 5.166

6.  Use and feasibility of delayed prescribing for respiratory tract infections: a questionnaire survey.

Authors:  Sigurd Høye; Jan C Frich; Morten Lindbæk
Journal:  BMC Fam Pract       Date:  2011-05-18       Impact factor: 2.497

Review 7.  Antibiotic use for acute respiratory tract infections (ARTI) in primary care; what factors affect prescribing and why is it important? A narrative review.

Authors:  Ray O'Connor; Jane O'Doherty; Andrew O'Regan; Colum Dunne
Journal:  Ir J Med Sci       Date:  2018-03-12       Impact factor: 1.568

8.  Systematic review of patient-oriented interventions to reduce unnecessary use of antibiotics for upper respiratory tract infections.

Authors:  Sameh Mortazhejri; Patrick Jiho Hong; Ashley M Yu; Brian Younho Hong; Dawn Stacey; R Sacha Bhatia; Jeremy M Grimshaw
Journal:  Syst Rev       Date:  2020-05-08

Review 9.  Delayed antibiotic prescriptions for respiratory infections.

Authors:  Geoffrey Kp Spurling; Chris B Del Mar; Liz Dooley; Ruth Foxlee; Rebecca Farley
Journal:  Cochrane Database Syst Rev       Date:  2017-09-07

Review 10.  Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy.

Authors:  Christian G Daughton
Journal:  Environ Health Perspect       Date:  2003-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.